#2374 on the rich list of 14,644 insiders
Neil E. Stahl
EVP Research and Development at Regeneron Pharmaceuticals. Based in Tarrytown, New York.
$54.7M
in disclosed stock, −$1.3M (−2.35%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 2374th of 14,644
- Companies held
- 1
- Largest holding
- REGN, 100.0% of total
- Latest SEC filing
- Dec 16, 2024
What the $54.7M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN Common Stock | Directly | 48,829 | $923.34 | $45.1M | 82.4% | Form 4, Dec 16, 2024 |
| Regeneron Pharmaceuticals REGN Common Stock | Through 401(k) Plan | 5,849 | $923.34 | $5.4M | 9.9% | Form 4, Dec 16, 2024 |
| Regeneron Pharmaceuticals REGN Common Stock | Through Spouse as Trustee | 4,605 | $923.34 | $4.3M | 7.8% | Form 4, Dec 16, 2024 |
Share counts are the amounts Neil E. Stahl reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2371 | 7 Cooperative Ua Lsp Director, Evommune | $54.8M |
| 2372 | Naarden Jacob Van EVP,Pres LLY Oncology&HdCorpBD, Eli Lilly and. Indianapolis, IN | $54.8M |
| 2373 | Anshul Sadana SVP, Chief Operating Officer, Arista Networks. Santa Clara, CA | $54.8M |
| 2374 | Neil E. Stahl EVP Research and Development, Regeneron Pharmaceuticals. Tarrytown, NY | $54.7M |
| 2375 | Michael C. Colby President and COO, Goosehead Insurance. Westlake, TX | $54.7M |
| 2376 | Gary Bowman Chief Executive Officer, Bowman Consulting Group. Reston, VA | $54.7M |
| 2377 | James F. Cleary Chief Financial Officer, Cencora. Conshohocken, PA | $54.7M |
Other Regeneron Pharmaceuticals insiders
All REGN insiders- Leonard S. Schleifer$2.21BBd. Co-Chair, President & CEO. #141 overall
- George Yancopoulos$855MBd. Co-Chair, President & CSO. #312 overall
- P. Roy Vagelos$431MDirector. #529 overall
- Andrew Murphy$47.3MCo-Chief Scientific Officer. #2647 overall
- Joseph LaRosa$44.4MEVP General Counsel and Secret. #2766 overall
- Daniel P. Van Plew$32.5MEVP & General Mgr, Industrial. #3541 overall
Questions
How much stock does Neil E. Stahl own?
Neil E. Stahl holds $54,738,365 in listed stock based on SEC filings and current prices, mostly Regeneron Pharmaceuticals (REGN). That ranks 2374th on the Stock Rich List.
Is this Neil E. Stahl's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.